Stay updated on Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Sign up to get notified when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.

Latest updates to the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page
- Check5 days agoChange DetectedThe page’s revision tag has been updated from v3.5.4 to v3.5.5, indicating a software or interface update. There is no evident change to the study content or its presented information.SummaryDifference0.1%

- Check12 days agoNo Change Detected
- Check19 days agoChange DetectedThe page now omits the sponsor name AbbVie, the 'clinical study report synopsis' label, and the 'Helpful Links Provided by' header, changing how the study details are presented and navigated.SummaryDifference0.2%

- Check26 days agoChange DetectedRevision label updated from v3.5.3 to v3.5.4. This represents a minor build/version update with no changes to study content or visible page information.SummaryDifference0.1%

- Check40 days agoChange DetectedRevision: v3.5.3 is now listed, replacing Revision: v3.5.2. This reflects a software release update for the site rather than a change to trial data or page content.SummaryDifference0.1%

- Check55 days agoChange DetectedThe page now shows Revision: v3.5.2, replacing Revision: v3.5.0.SummaryDifference0.1%

- Check83 days agoChange DetectedRevision history updated: added Revision: v3.5.0 and removed Revision: v3.4.3. This appears to be an internal maintenance update and does not affect study details.SummaryDifference0.1%

Stay in the know with updates to Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Comparison of Risankizumab vs Methotrexate in Psoriasis Clinical Trial page.